inVentiv Health Acquires Pharma Consultancy

US-based marketing firm inVentiv Health has acquired Addison Whitney Healthcare, a company providing research-based brand identity solutions to global pharmaceutical, biotechnology and medical clients. Financial terms of the transaction were not disclosed.

Addison Whitney offers a range of services to create, renew and strengthen brands, including market research for testing pharmaceutical trade names, and customised brand-focused research to gauge how appealing each trade name is from a marketing communication perspective.

inVentiv Health's President, Blane Walter, says of the acquisition: 'Addison Whitney Healthcare is an industry leader in partnering with pharmaceutical and biotech companies to create strong, recognisable identities for their products. Their expertise in developing brand names, along with their long-standing customer relationships and their ability to serve clients very early in the product lifecycle, will directly complement and broaden the suite of offerings within inVentiv Communications.'

Clayton Tolley, President and CEO of Addison Whitney, comments: 'We are joining with inVentiv Health because they share our passion for the business and because of their track record of growth and success in the healthcare market.'

Addison Whitney, which was founded in 1991, will become a wholly- owned subsidiary of inVentiv Health, retaining its brand and operating within the inVentiv Communications division under the leadership of William O'Donnell, who was recently named President and COO of inVentiv Communications. The two firms are online at www.addisonwhitneyhc.com and www.ventiv.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.